Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
ICICI Bank: Restoring Faith in Corporate Governance - Teaching Note
Arpita Agnihotri; Saurabh BhattacharyaNota del Instructor IVEY-8B19M065-EDirección estratégicaTeaching note for product 9B19M065.Desde 0,00 €
-
Marsh USA Inc.: Challenges of Pandemic Insurance in a COVID-19 World - Teaching Note
Arpita Agnihotri; Saurabh BhattacharyaNota del Instructor IVEY-8B21M012-EDirección estratégicaTeaching note for product 9B21M012.Desde 0,00 €
-
Meta: A New Direction To Leadership
Arpita Agnihotri; Saurabh BhattacharyaCaso IVEY-W27712-ELiderazgo y Dirección de personasOn October 28, 2021, Mark Zuckerberg, founder, chief executive officer, and chair of Facebook Inc. (Facebook), announced Facebook’s name change to Meta Platforms Inc., reflecting his vision for the company’s transition to metaverse technology. At the same time, Facebook was plagued by multiple scandals related to a data privacy breach, the spread of misinformation on the social media platform, employee whistle-blowing, and surveillance-style mark...Desde 8,20 €
-
India Post
Arpita Agnihotri; Saurabh BhattacharyaCaso IVEY-9B13M119-EDirección estratégicaThe advent of the world wide web and the entry of private players in India’s post-liberalization era resulted in India Post losing a substantial volume of its business to e-mails, faxes, short-message services and private-courier-service providers. Additionally, government policies regarding India Post had long remained unchanged. As a consequence, India Post was caught up in a vicious cycle of decreasing mail traffic, low levels of technology in...Desde 8,20 €
-
Moderna: In Search of a Competitive Edge in the COVID-19 Vaccine Race
Saurabh Bhattacharya; Arpita AgnihotriCaso IVEY-9B21M058-EDirección estratégica, MarketingModerna, Inc. (Moderna), a US biotech start-up, was a contender in the race to develop a COVID-19 vaccine. On November 23, 2020, Moderna announced success in the third-stage clinical trial of its COVID-19 vaccine, soon after larger rival Pfizer Inc. (Pfizer), partnering with BioNTech SE, had reported the successful clinical trial results of its own vaccine. However, large-scale vaccine production was a challenge for Moderna, and its chief executi...Desde 8,20 €